ACKR3 and coronary artery disorder: Our previous investigation showed an enhanced surface availability of ACKR3/CXCR7 on circulating platelets in CAD patients [23,25], and the possibility of regulating thrombotic response through ACKR3/CXCR7, with MIF [40].